Differential Effects of Lipid-Lowering Therapies on Stroke Prevention
Open Access
- 24 March 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 163 (6) , 669-676
- https://doi.org/10.1001/archinte.163.6.669
Abstract
Review from JAMA Internal Medicine — Differential Effects of Lipid-Lowering Therapies on Stroke Prevention — A Meta-analysis of Randomized TrialsThis publication has 37 references indexed in Scilit:
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Statins as a newly recognized type of immunomodulatorNature Medicine, 2000
- Cholesterol Reduction and Stroke Occurrence: An Overview of Randomized Clinical TrialsCerebrovascular Diseases, 2000
- Current Perspectives on StatinsCirculation, 2000
- Incidence and Occurrence of Total (First-Ever and Recurrent) StrokeStroke, 1999
- Neuroprotective Properties of Statins in Cerebral Ischemia and StrokeStroke, 1999
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Antiatherothrombotic properties of statins. Implications for cardiovascular event reductionJournal of Cardiothoracic and Vascular Anesthesia, 1999
- Vascular Effects of Statins in StrokeStroke, 1997
- Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trialsPublished by American Medical Association (AMA) ,1997